Study shows decrease in active hepatitis C infection among risk groups

HCV: hepatitis C virus; IDU: injecting drug use; PWID: people who inject drugs; PWUD: people who use drugs. Credit: Eurosurveillance A study conducted through a mobile screening unit in Madrid, Spain from 2017 to 2023 and published in Eurosurveillance found that active hepatitis C virus (HCV) infection decreased from 23% to 6% in that period among people who use drugs (PWUD) that visited the unit. The study found that the use of intravenous drugs was the most significant risk factor for infection among PWUD. It confirmed that HCV screening and treatment programs targeting this at-risk population are effective and can Read More